The ac­cel­er­at­ed ap­proval path­way is evolv­ing in plain sight, with or with­out con­gres­sion­al help

FDA lead­ers have made clear that re­form­ing the ac­cel­er­at­ed ap­proval path­way is a pri­or­i­ty, and with sev­er­al re­cent ac­tions, the agency has sig­naled that it’ …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER